| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DTST | Stock Options | Award | $0 | +15.5K | $0.00 | 15.5K | Jan 2, 2024 | Common Stock | 15.5K | $3.22 | Direct | F6 |
Charles M. Piluso is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
| Id | Content |
|---|---|
| F1 | Represents the shares of the Issuer's common stock underlying a restricted stock unit ("RSU") grant to the Reporting Person on January 2, 2024, which RSUs vest over a three-year period, in three equal annual installments starting on January 2, 2025; January 2, 2026; and January 2, 2027, subject to the Reporting Person's continued service to the Issuer through each vesting date. |
| F2 | The Reporting Person is a Managing Member of Piluso Family Associates, together with his spouse. |
| F3 | The Reporting Person is a Managing Member of of Piluso Family Associates LLC, together with his spouse. |
| F4 | The Reporting Person's spouse is the beneficiary of The Lasata 2012 Trust dated 5/4/12 ("The Lasata Trust") and the Reporting Person's spouse, together with Lawrence Maglione, a director of the Issuer, are the co-trustees of the Lasata Trust. |
| F5 | The Reporting Person is the beneficiary of The Bella Vita 2012 Trust dated 5/4/12 ("The Bella Vita Trust") and the Reporting Person, together with his spouse, are the co-trustees thereof. |
| F6 | These options vest and become exercisable in three equal annual installments over the three-year period measured from January 2, 2024, vesting commencing on January 2, 2025, with an exercise price equal to 110% of the closing price of the Issuer's common stock as of the date of grant. |